Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Weber

Showing results (851-860 of 880) with videos related to

Pageof 88
Sort By:
Leukemia|July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupF Theis, A Corbacioglu, V I Gaidzik, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
The American Journal of Pathology|July 28, 2004
Vascular gene expression in nonneoplastic and malignant brainStephen L Madden, Brian P Cook, Mariana Nacht, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Leukemia|January 19, 2017
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemiaR F Schlenk, P Frech, D Weber, et al.
Blood Cancer Journal|May 27, 2017
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemiaS Jaramillo, A Benner, J Krauter, et al.
Annals of Hematology|November 2, 2017
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)Gabriele Nagel, D Weber, E Fromm, et al.
Molecular Therapy. Methods & Clinical Development|January 21, 2021
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized miceDaniel Stone, Kelly R Long, Michelle A Loprieno, et al.
Journal of Neural Engineering|March 1, 2016
Brain-computer interface devices for patients with paralysis and amputation: a meeting reportK Bowsher, E F Civillico, J Coburn, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Pageof 88

Showing results (851-860 of 880) with videos related to

Sort By:
Pageof 88
Leukemia|July 5, 2016
Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study groupF Theis, A Corbacioglu, V I Gaidzik, et al.
The Journal of Experimental Medicine|March 23, 2023
Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapyChong Zuo, John M Baer, Brett L Knolhoff, et al.
The American Journal of Pathology|July 28, 2004
Vascular gene expression in nonneoplastic and malignant brainStephen L Madden, Brian P Cook, Mariana Nacht, et al.
Leukemia|February 8, 2019
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidineR F Schlenk, D Weber, W Herr, et al.
Leukemia|January 19, 2017
Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemiaR F Schlenk, P Frech, D Weber, et al.
Blood Cancer Journal|May 27, 2017
Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemiaS Jaramillo, A Benner, J Krauter, et al.
Annals of Hematology|November 2, 2017
Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)Gabriele Nagel, D Weber, E Fromm, et al.
Molecular Therapy. Methods & Clinical Development|January 21, 2021
CRISPR-Cas9 gene editing of hepatitis B virus in chronically infected humanized miceDaniel Stone, Kelly R Long, Michelle A Loprieno, et al.
Journal of Neural Engineering|March 1, 2016
Brain-computer interface devices for patients with paralysis and amputation: a meeting reportK Bowsher, E F Civillico, J Coburn, et al.
Nature Communications|September 19, 2018
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H Wagner, Siddhartha Devarakonda, Zachary L Skidmore, et al.
Pageof 88